BillionToOne, Inc.
NASDAQ:BLLNMedical - Diagnostics & Research
+$0.84 today
- Market cap
- $4.37B
- Beta
- 0.90
- P/E (TTM)
- 182.6
- EPS (TTM)
- $0.55
Volume 1.44M
Average 0.59M
Income Statement
Follow revenue through to earnings.
Revenue
$305.11M
FY 2025 · Annual
+100.0% YoYOperating Income
$16.02M
FY 2025 · Annual
Net Income
$7.45M
FY 2025 · Annual
Income Statement
Metric | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|
| Revenue | 71.73M | 152.58M | 305.11M |
| Cost of Revenue | 54.42M | 71.67M | 96.65M |
| Gross Profit | 17.31M | 80.92M | 208.46M |
| Gross Margin | 24.1% | 53.0% | 68.3% |
| Research & Development | 22.41M | 36.6M | 49.38M |
| Selling, General & Admin | 64.39M | 91.47M | 143.05M |
| Operating Expenses | 86.8M | 128.06M | 192.44M |
| Depreciation & Amortization | 6.46M | 11.69M | 11.91M |
| EBITDA | (72.94M) | (27.47M) | 19.76M |
| EBITDA Margin | -101.7% | -18.0% | 6.5% |
| Operating Income | (69.5M) | (47.15M) | 16.02M |
| Operating Margin | -96.9% | -30.9% | 5.3% |
| Interest Income | 3.46M | 5.82M | 7.75M |
| Interest Expense | 3.27M | 2.39M | 95K |
| Other Income / Expenses | (13.18M) | 5.61M | (8.26M) |
| Income Before Tax | (82.67M) | (41.54M) | 7.76M |
| Pre-Tax Margin | -115.3% | -27.2% | 2.5% |
| Income Tax Expense | 9K | 29K | 305K |
| Net Income | (82.68M) | (41.57M) | 7.45M |
| Net Margin | -115.3% | -27.2% | 2.4% |
| EPS (Basic) | (1.85) | (0.93) | 0.06 |
| EPS (Diluted) | (1.85) | (0.93) | 0.06 |
| 44.72M | 44.72M | 45.8M | |
| 44.72M | 44.72M | 45.8M |
BLLN Earnings Waterfall · TTM
NASDAQ:BLLN · Revenue to Net Income
Key Ratios
Analysis
$397.4M of revenue converted into $33.5M of net income for the selected period. Gross margin is 71.2% and net margin is 8.0%, showing how much revenue survives after costs and taxes. EPS is $0.62, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Nov 12, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 10, 2026 | |
| SC 13D/A | SC 13D/A filing | Nov 9, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 4, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 4, 2026 |
How much revenue does BLLN generate?
BillionToOne, Inc. (BLLN) reported $305.11M of revenue in fiscal 2025.
Is BLLN profitable?
BillionToOne, Inc. (BLLN) reported $7.45M of net income, with a net margin of 2.4%.
Continue the stock analysis
Jump to another research area for this company.